448 related articles for article (PubMed ID: 9098518)
1. Heterogeneity of signal transduction mechanisms in human basophils and human skin mast cells. II. Effects of 7-O-methyl-UCN-01, NPC 15437 and bryostatin 1 and 2, four protein kinase C-modulatory agents, on mediator release.
Noll T; Dieckmann D; Gibbs BF; Nitschke M; Albrecht C; Vollrath I; Tamaoki T; Wolff HH; Amon U
Biol Signals; 1997; 6(1):1-10. PubMed ID: 9098518
[TBL] [Abstract][Full Text] [Related]
2. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
3. The antineoplastic bryostatins affect human basophils and mast cells differently.
Patella V; Casolaro V; Ciccarelli A; Pettit GR; Columbo M; Marone G
Blood; 1995 Mar; 85(5):1272-81. PubMed ID: 7532037
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.
Warner JA; MacGlashan DW
J Immunol; 1990 Sep; 145(6):1897-905. PubMed ID: 1697313
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition.
Massey WA; Cohan VL; MacGlashan DW; Gittlen SW; Kagey-Sobotka A; Lichtenstein LM; Warner JA
J Pharmacol Exp Ther; 1991 Sep; 258(3):824-9. PubMed ID: 1716311
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
Cirillo R; Triggiani M; Siri L; Ciccarelli A; Pettit GR; Condorelli M; Marone G
J Immunol; 1990 May; 144(10):3891-7. PubMed ID: 1692065
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of human skin mast cells and human basophils. I. Pharmacological experiments with activators and inhibitors of protein kinase C.
Amon U; Dieckmann D; Nitschke M; von Stebut E; Gibbs BF; Wolff HH
Skin Pharmacol; 1996; 9(3):211-20. PubMed ID: 8737919
[TBL] [Abstract][Full Text] [Related]
8. CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils.
Amon U; von Stebut E; Subramanian N; Wolff HH
Pharmacology; 1993 Sep; 47(3):200-8. PubMed ID: 7692457
[TBL] [Abstract][Full Text] [Related]
9. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
[TBL] [Abstract][Full Text] [Related]
10. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
11. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.
Bergstrand H; Lundquist B; Karabelas K; Michelsen P
J Pharmacol Exp Ther; 1992 Mar; 260(3):1028-37. PubMed ID: 1372047
[TBL] [Abstract][Full Text] [Related]
12. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
13. Role of tyrosine kinases in IgE-mediated signal transduction in human lung mast cells and basophils.
Lavens SE; Peachell PT; Warner JA
Am J Respir Cell Mol Biol; 1992 Dec; 7(6):637-44. PubMed ID: 1280450
[TBL] [Abstract][Full Text] [Related]
14. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.
Wang S; Wang Z; Grant S
Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556
[TBL] [Abstract][Full Text] [Related]
15. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
16. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological investigations with different protein kinase C inhibitors on IgE-dependent and IgE-independent activation of human basophils.
Amon U; von Stebut E; Wolff HH
Agents Actions; 1993 May; 39(1-2):13-9. PubMed ID: 7506863
[TBL] [Abstract][Full Text] [Related]
18. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
19. Effects of ADP-ribosylation of GTP-binding protein by pertussis toxin on immunoglobulin E-dependent and -independent histamine release from mast cells and basophils.
Saito H; Okajima F; Molski TF; Sha'afi RI; Ui M; Ishizaka T
J Immunol; 1987 Jun; 138(11):3927-34. PubMed ID: 2438330
[TBL] [Abstract][Full Text] [Related]
20. Investigations with the selective PKC inhibitor chelerythrine on human basophils.
von Stebut E; Amon U; Herbert JM; Wolff HH
Agents Actions; 1994 Jun; 41 Spec No():C56-7. PubMed ID: 7526660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
